Home -> Law Blog Directory -> Insurance Law Blogs -> Declarations and Exclusions
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Insurance Law
: Declarations and ExclusionsBlawg Review is Waiting in the Wings
By George M. Wallace
What lies behind the ominous curtains?
The return, to these pages, of Blawg Review, the blog carnival for lawyers and everyone interested in the law.
Please join Decs&Excs on Monday, March 28, 2011, for Blawg Review #304. Be warned, however, that this edition will not be without Risk.
This will mark the fourth Blawg Review excursion in the past five years for this blog. In keeping with tradition, the edition following #304 is scheduled to appear the following week on my personal/cultural blog, a fool in the forest.
Decs&Excs welcomes submissions of the best, most intriguing, most noteworthy law-related blog posts of this week, to be considered for inclusion in BR #304. Submissions can be directed via email to post@blawgreview.com, or through the Blawg Review submissions page. Detailed information on submission guidelines can be found here.
In the meantime, the current week's edition?Blawg Review #303?is being hosted at the Blawg Review main site, under the auspices of the Anonymous Editor of Blawg Review. Please direct your attention there while I continue to prepare for the revelation of edition #304 five days hence. Thank you, and good blawgs to you.
~~~
Full post as published by Declarations and Exclusions on March 23, 2011 (boomark / email).
FDA Issues Update on Safety Review Orlistat
Orlistat FDA Issues Update on Safety Review
Aurora Loan Faces Class Action over Mortgage Review Services
Aurora Loan Faces Class Action over Mortgage Review Services
FDA Review of Prostate Cancer Treatment Prompts Warning of Risk for Diabetes
Prostate Cancer Treatment FDA Review Prompts Warning of Risk for Diabetes
Xigris
Study Prompts FDA Safety Review
Lipitor
Review of Studies Show No Significant Benefit in Women
Wrinkle-Fillers
FDA to Review Labeling due to Adverse Event Reports









